Annual Retained Earnings
-$390.61 M
-$60.61 M-18.37%
December 31, 2023
Summary
- As of February 7, 2025, BLRX annual retained earnings is -$390.61 million, with the most recent change of -$60.61 million (-18.37%) on December 31, 2023.
- During the last 3 years, BLRX annual retained earnings has fallen by -$112.62 million (-40.51%).
- BLRX annual retained earnings is now -303.90% below its all-time high of -$96.71 million, reached on December 31, 2011.
Performance
BLRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$396.64 M
-$5.82 M-1.49%
September 1, 2024
Summary
- As of February 7, 2025, BLRX quarterly retained earnings is -$396.64 million, with the most recent change of -$5.82 million (-1.49%) on September 1, 2024.
- Over the past year, BLRX quarterly retained earnings has dropped by -$19.92 million (-5.29%).
- BLRX quarterly retained earnings is now -321.52% below its all-time high of -$94.10 million, reached on March 1, 2011.
Performance
BLRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BLRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.4% | -5.3% |
| 3 y3 years | -40.5% | -31.9% |
| 5 y5 years | -75.5% | -31.9% |
BLRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.1% | at low | -30.0% | at low |
| 5 y | 5-year | -57.5% | at low | -60.0% | at low |
| alltime | all time | -303.9% | at low | -321.5% | at low |
BioLineRx Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$396.64 M(+1.5%) |
| Jun 2024 | - | -$390.82 M(-0.1%) |
| Mar 2024 | - | -$391.30 M(+0.2%) |
| Dec 2023 | -$390.61 M(+18.4%) | -$390.61 M(+3.7%) |
| Sep 2023 | - | -$376.72 M(+4.4%) |
| Jun 2023 | - | -$360.70 M(+5.4%) |
| Mar 2023 | - | -$342.15 M(+3.7%) |
| Dec 2022 | -$329.99 M(+8.2%) | -$329.99 M(+1.8%) |
| Sep 2022 | - | -$324.26 M(+2.2%) |
| Jun 2022 | - | -$317.41 M(+2.4%) |
| Mar 2022 | - | -$309.97 M(+1.6%) |
| Dec 2021 | -$305.04 M(+9.7%) | -$305.04 M(+1.4%) |
| Sep 2021 | - | -$300.74 M(+1.9%) |
| Jun 2021 | - | -$295.02 M(+2.4%) |
| Mar 2021 | - | -$288.18 M(+3.7%) |
| Dec 2020 | -$277.99 M(+12.1%) | -$277.99 M(+4.5%) |
| Sep 2020 | - | -$266.00 M(+1.8%) |
| Jun 2020 | - | -$261.38 M(+2.7%) |
| Mar 2020 | - | -$254.61 M(+2.7%) |
| Dec 2019 | -$247.97 M(+11.4%) | -$247.97 M(+4.1%) |
| Sep 2019 | - | -$238.10 M(+1.7%) |
| Jun 2019 | - | -$234.16 M(+2.4%) |
| Mar 2019 | - | -$228.68 M(+2.8%) |
| Dec 2018 | -$222.52 M(+11.5%) | -$222.52 M(+2.6%) |
| Sep 2018 | - | -$216.87 M(+3.0%) |
| Jun 2018 | - | -$210.54 M(+2.3%) |
| Mar 2018 | - | -$205.76 M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | -$199.56 M(+13.9%) | -$199.56 M(+3.8%) |
| Sep 2017 | - | -$192.20 M(+3.9%) |
| Jun 2017 | - | -$184.96 M(+2.7%) |
| Mar 2017 | - | -$180.06 M(+2.8%) |
| Dec 2016 | -$175.21 M(+9.9%) | -$175.21 M(+2.5%) |
| Sep 2016 | - | -$170.92 M(+2.6%) |
| Jun 2016 | - | -$166.59 M(+2.3%) |
| Mar 2016 | - | -$162.85 M(+2.2%) |
| Dec 2015 | -$159.37 M(+9.9%) | -$159.37 M(+2.3%) |
| Sep 2015 | - | -$155.71 M(+1.1%) |
| Jun 2015 | - | -$154.09 M(+3.2%) |
| Mar 2015 | - | -$149.28 M(+3.0%) |
| Dec 2014 | -$144.97 M(+8.3%) | -$144.97 M(+0.8%) |
| Sep 2014 | - | -$143.75 M(-6.4%) |
| Jun 2014 | - | -$153.61 M(+4.8%) |
| Mar 2014 | - | -$146.55 M(+9.5%) |
| Dec 2013 | -$133.89 M(+12.6%) | -$133.89 M(-2.6%) |
| Sep 2013 | - | -$137.45 M(+6.1%) |
| Jun 2013 | - | -$129.59 M(+3.6%) |
| Mar 2013 | - | -$125.13 M(+5.2%) |
| Dec 2012 | -$118.94 M(+23.0%) | -$118.94 M(+11.6%) |
| Sep 2012 | - | -$106.60 M(+5.0%) |
| Jun 2012 | - | -$101.53 M(-2.3%) |
| Mar 2012 | - | -$103.91 M(+7.4%) |
| Dec 2011 | -$96.71 M | -$96.71 M(+2.3%) |
| Sep 2011 | - | -$94.50 M(-6.5%) |
| Jun 2011 | - | -$101.03 M(+7.4%) |
| Mar 2011 | - | -$94.10 M |
FAQ
- What is BioLineRx annual retained earnings?
- What is the all time high annual retained earnings for BioLineRx?
- What is BioLineRx annual retained earnings year-on-year change?
- What is BioLineRx quarterly retained earnings?
- What is the all time high quarterly retained earnings for BioLineRx?
- What is BioLineRx quarterly retained earnings year-on-year change?
What is BioLineRx annual retained earnings?
The current annual retained earnings of BLRX is -$390.61 M
What is the all time high annual retained earnings for BioLineRx?
BioLineRx all-time high annual retained earnings is -$96.71 M
What is BioLineRx annual retained earnings year-on-year change?
Over the past year, BLRX annual retained earnings has changed by -$60.61 M (-18.37%)
What is BioLineRx quarterly retained earnings?
The current quarterly retained earnings of BLRX is -$396.64 M
What is the all time high quarterly retained earnings for BioLineRx?
BioLineRx all-time high quarterly retained earnings is -$94.10 M
What is BioLineRx quarterly retained earnings year-on-year change?
Over the past year, BLRX quarterly retained earnings has changed by -$19.92 M (-5.29%)